Center for Scientific Review; Notice of Closed Meetings, 12388-12389 [2023-03969]
Download as PDF
12388
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
Inpatient Hospital per Diem Rate
(Excludes Physician/Practitioner
Services)
Calendar Year 2023
Lower 48 States $4,333
Alaska $3,478
Outpatient per Visit Rate (Excluding
Medicare)
Calendar Year 2023
Lower 48 States $654
Alaska $862
Outpatient per Visit Rate (Medicare)
Calendar Year 2023
Lower 48 States $620
Alaska $801
Medicare Part B Inpatient Ancillary per
Diem Rate
Calendar Year 2023
Lower 48 States $829
Alaska $1,066
Outpatient Surgery Rate (Medicare)
Established Medicare rates for
freestanding Ambulatory Surgery
Centers.
Effective Date for Calendar Year 2023
Rates
Consistent with previous annual rate
revisions, the Calendar Year 2023 rates
will be effective for services provided
on or after January 1, 2023, to the extent
consistent with payment authorities,
including the applicable Medicaid State
plan.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2023–03896 Filed 2–24–23; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Oral, Dental and Craniofacial
Sciences Study Section.
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
Date: March 24, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Michael Lovering,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J,
Bethesda, MD 20892, (301) 867–5309,
loveringrm@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: The Cancer Biotherapeutics
Development (CBD).
Date: March 27–28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave. NW, Washington, DC 20037.
Contact Person: Laurie Ann Shuman Moss,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, laurie.shumanmoss@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Genetics and Genomics.
Date: March 27, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mollie Kim Manier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0510, mollie.manier@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Viral
Dynamics and Transmission.
Date: March 28–29, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sharon Isern, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 810J,
Bethesda, MD 20892, (301) 435–0000,
iserns2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immunity and Host Defense.
Date: March 28, 2023.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deanna C Bublitz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
20892, (301) 594–4005, deanna.bublitz@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Motor Control and Rehabilitation.
Date: March 28, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, (301) 443–7193,
hargravesl@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR21–089
Specific Pathogen Free Macaque Colonies
(U42 Clinical Trial Not Allowed).
Date: March 28, 2023.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anthony Wing Sang Chan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809K,
Bethesda, MD 20892, (301) 496–9392,
chana3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Biology of Aging and Infection.
Date: March 28, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6107 Rockledge Drive, Bethesda, MD
20892, (301) 402–8559, jimok.kim@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Epidemiology and Population
Health.
Date: March 28, 2023.
Time: 12:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Tisdale Wigfall, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007G,
Bethesda, MD 20892, (301) 594–5622,
wigfalllt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Respiratory Sciences.
Date: March 29–30, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27FEN1.SGM
27FEN1
Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Imoh Sunday Okon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, 301–347–8881, imoh.okon@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 22, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–03969 Filed 2–24–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; RFA:
Expanding Prevention Strategies for Mental
Disorders in Mobile Populations in
Humanitarian Crises.
Date: March 22, 2023.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Regina Dolan-Sewell,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20852, (240) 796–6785,
regina.dolan-sewell@nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Pathway to Independence Awards (K99/R00)
A.
Date: March 23, 2023.
VerDate Sep<11>2014
20:06 Feb 24, 2023
Jkt 259001
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: David W. Miller, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892–9608, 301–443–9734,
millerda@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Addressing Mental Health Disparities
Research Gaps: Aggregating and Mining
Existing Data Sets for Secondary Analyses
(R01).
Date: March 23, 2023.
Time: 11:00 a.m. to 4:15 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Rebecca Steiner Garcia,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892–9608, 301–443–4525,
steinerr@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
BRAIN Initiative: Integration and Analysis of
BRAIN Initiative Data.
Date: March 23, 2023.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Jasenka Borzan, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Mental Health, Neuroscience Center, 6001
Executive Blvd., Bethesda, MD 20892, 301–
435–1260, jasenka.borzan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: February 21, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–03918 Filed 2–24–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
12389
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2022–0051]
National Flood Insurance Program
(NFIP); Assistance to Private Sector
Property Insurers, Notice of FY 2024
Arrangement
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
The Federal Emergency
Management Agency announces the
Fiscal Year 2024 Financial Assistance/
Subsidy Arrangement for private
property insurers interested in
participating in the National Flood
Insurance Program’s Write Your Own
Program.
SUMMARY:
Interested insurers must submit
intent to subscribe or re-subscribe to the
Arrangement by May 30, 2023.
FOR FURTHER INFORMATION CONTACT:
Sarah Devaney Ice, Federal Insurance
and Mitigation Administration, FEMA,
400 C St. SW, Washington, DC 20472
(mail); (202) 320–5577 (phone); or
sarah.devaney-ice@fema.dhs.gov
(email).
DATES:
SUPPLEMENTARY INFORMATION:
I. Background
The National Flood Insurance Act of
1968 (NFIA) (42 U.S.C. 4001 et seq.)
authorizes the Administrator of the
Federal Emergency Management Agency
(FEMA) to establish and carry out a
National Flood Insurance Program
(NFIP) to enable interested persons to
purchase flood insurance. See 42 U.S.C.
4011(a). Under the NFIA, FEMA may
use insurance companies and other
insurers, insurance agents and brokers,
and insurance adjustment organizations
as fiscal agents of the United States to
help it carry out the NFIP. See 42 U.S.C.
4071. To this end, FEMA may ‘‘enter
into any contracts, agreements, or other
appropriate arrangements’’ with private
insurance companies to use their
facilities and services in administering
the NFIP on such terms and conditions
as they agree upon. See 42 U.S.C.
4081(a).
Pursuant to this authority, FEMA
enters into a standard Financial
Assistance/Subsidy Arrangement
(Arrangement) with private sector
property insurers, also known as Write
Your Own (WYO) companies, to sell
NFIP flood insurance policies under
their own names and adjust and pay
E:\FR\FM\27FEN1.SGM
27FEN1
Agencies
[Federal Register Volume 88, Number 38 (Monday, February 27, 2023)]
[Notices]
[Pages 12388-12389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03969]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Oral, Dental and Craniofacial Sciences Study
Section.
Date: March 24, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Richard Michael Lovering, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J, Bethesda, MD 20892, (301)
867-5309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: The Cancer Biotherapeutics Development (CBD).
Date: March 27-28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Ave. NW, Washington, DC
20037.
Contact Person: Laurie Ann Shuman Moss, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Molecular Genetics and Genomics.
Date: March 27, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mollie Kim Manier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0510,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Viral Dynamics and Transmission.
Date: March 28-29, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sharon Isern, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 810J, Bethesda, MD 20892, (301) 435-0000,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Immunity and Host Defense.
Date: March 28, 2023.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deanna C Bublitz, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-4005,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Motor Control and Rehabilitation.
Date: March 28, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301)
443-7193, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR21-089 Specific Pathogen Free Macaque Colonies (U42
Clinical Trial Not Allowed).
Date: March 28, 2023.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anthony Wing Sang Chan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809K, Bethesda, MD 20892, (301)
496-9392, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Biology of Aging and Infection.
Date: March 28, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6107
Rockledge Drive, Bethesda, MD 20892, (301) 402-8559,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Epidemiology and Population Health.
Date: March 28, 2023.
Time: 12:00 p.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Tisdale Wigfall, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301)
594-5622, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Respiratory Sciences.
Date: March 29-30, 2023.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 12389]]
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Imoh Sunday Okon, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301-347-8881,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 22, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-03969 Filed 2-24-23; 8:45 am]
BILLING CODE 4140-01-P